{"id":"salmon-calcitonin","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Nausea"},{"rate":"5-15","effect":"Flushing"},{"rate":"5-10","effect":"Injection site reactions"},{"rate":"5-10","effect":"Headache"},{"rate":"5","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":{"setId":"ece693d8-1832-4b85-8736-819163ba56c1","title":"CALCITONIN SALMON INJECTION, SOLUTION [PAR HEALTH USA, LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Calcitonin is a 32-amino acid peptide that acts as a potent inhibitor of osteoclast-mediated bone resorption. It binds to calcitonin receptors on the surface of osteoclasts, causing them to retract from the bone surface and reducing their resorptive activity. This leads to decreased serum calcium and phosphate levels and is used therapeutically in conditions characterized by elevated bone turnover or hypercalcemia.","oneSentence":"Salmon calcitonin is a peptide hormone that binds to calcitonin receptors on osteoclasts to inhibit bone resorption and lower serum calcium levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:06:48.168Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Paget's disease of bone"},{"name":"Hypercalcemia of malignancy"},{"name":"Osteoporosis in postmenopausal women"},{"name":"Acute bone loss following immobilization"}]},"trialDetails":[{"nctId":"NCT07261371","phase":"PHASE1","title":"A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-11-24","conditions":"Healthy Volunteer","enrollment":64},{"nctId":"NCT03898856","phase":"PHASE4","title":"Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2019-04-01","conditions":"Chronic Diarrhea of Unknown Origin","enrollment":93},{"nctId":"NCT06330168","phase":"NA","title":"Paravertebral Calcitonin in Thoracotomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2024-03-28","conditions":"Calcitonin, Paravertebral, Thoracotomy","enrollment":92},{"nctId":"NCT07330024","phase":"","title":"Evaluation of Pulpal and Salivary Neuropeptides in Dental Pain","status":"COMPLETED","sponsor":"Kahramanmaras Sutcu Imam University","startDate":"2024-11-01","conditions":"Dental Pain, Pulpitis, Pulpal Inflammation","enrollment":72},{"nctId":"NCT05217927","phase":"PHASE4","title":"Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens","status":"COMPLETED","sponsor":"Pfizer","startDate":"2022-03-04","conditions":"Migraine","enrollment":1415},{"nctId":"NCT01977079","phase":"NA","title":"Procalcitonin and Threatened Premature Delivery","status":"TERMINATED","sponsor":"Centre Hospitalier Departemental Vendee","startDate":"2013-12","conditions":"Pregnancy, Premature Delivery","enrollment":131},{"nctId":"NCT07203248","phase":"","title":"Chinese Real-world Study of Treatment of Vestibular Migraine","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-12","conditions":"Vestibular Migraine, Dizziness, Vertigo","enrollment":2000},{"nctId":"NCT07159750","phase":"","title":"Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine","status":"RECRUITING","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2024-01-02","conditions":"Migraine, Episodic Migraine, Chronic Migraine, Headache","enrollment":700},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT07021859","phase":"NA","title":"Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide","status":"RECRUITING","sponsor":"Danish Headache Center","startDate":"2025-06-27","conditions":"Migraine Aura, Migraine With Aura","enrollment":21},{"nctId":"NCT07103694","phase":"","title":"i-NEED: NEw migrainE Drugs Database","status":"RECRUITING","sponsor":"IRCCS San Raffaele Roma","startDate":"2022-03-24","conditions":"Episodic Migraine, Chronic Migraine, Medication Overuse Headache","enrollment":2641},{"nctId":"NCT07029373","phase":"","title":"Plasma Calcitonin Gene-Related Peptide (CGRP) Levels in Patients With Head and Neck Malignancies Undergoing Radiotherapy","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2025-07-04","conditions":"Head and Neck Cancer","enrollment":50},{"nctId":"NCT07033104","phase":"NA","title":"Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-04-01","conditions":"Transversalis Fascia Plane Block","enrollment":70},{"nctId":"NCT05805683","phase":"NA","title":"Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-05-01","conditions":"Calcitonin, Neuropathic Pain, Spinal Cord Injury","enrollment":50},{"nctId":"NCT05570149","phase":"","title":"EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.","status":"RECRUITING","sponsor":"IRCCS San Raffaele Roma","startDate":"2023-01-01","conditions":"Migraine Disorders","enrollment":500},{"nctId":"NCT04445857","phase":"PHASE4","title":"Efficacy of Coadministration of Calcitonin and Hyperbaric Bupivacaine in Spinal Anesthesia in Tramadol-abuse Patients","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-09-01","conditions":"Analgesia","enrollment":90},{"nctId":"NCT03919266","phase":"NA","title":"Combined Use of a Respiratory Broad Panel Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Hospitalized Sickle-cell Adults With Acute Chest Syndrome.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-06-02","conditions":"Acute Chest Syndrome, Sickle Cell Disease","enrollment":72},{"nctId":"NCT05127980","phase":"","title":"Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-10-15","conditions":"Epstein-Barr Virus (EBV) Infection","enrollment":80},{"nctId":"NCT02088645","phase":"PHASE1","title":"177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2015-04","conditions":"Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2","enrollment":24},{"nctId":"NCT06833749","phase":"PHASE2","title":"Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis","status":"RECRUITING","sponsor":"KeyBioscience AG","startDate":"2025-01-28","conditions":"Osteoarthritis in the Knee, Obesity","enrollment":600},{"nctId":"NCT06004388","phase":"PHASE3","title":"Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)","status":"COMPLETED","sponsor":"Click Therapeutics, Inc.","startDate":"2023-07-21","conditions":"Migraine, Episodic Migraine, Headache","enrollment":110},{"nctId":"NCT04628429","phase":"","title":"CGRP Inhibition, Autonomic Function, and Migraine","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2020-10-01","conditions":"Episodic Migraine, Chronic Migraine","enrollment":120},{"nctId":"NCT05955612","phase":"PHASE3","title":"Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2023-07-26","conditions":"Sepsis","enrollment":532},{"nctId":"NCT06662461","phase":"NA","title":"Ultrasound Guided Block of Stellate Ganglion Versus Greater Occipital Nerve in Resistant Migraine and Correlation to Calcitonin Gene Related Peptide","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-02-01","conditions":"Migraine","enrollment":40},{"nctId":"NCT03935984","phase":"PHASE4","title":"Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity","status":"RECRUITING","sponsor":"Joseph Sferra","startDate":"2019-05-29","conditions":"Primary Hyperparathyroidism, Hypercalcemia","enrollment":37},{"nctId":"NCT06549270","phase":"","title":"Biochemical Profiling of Migraine Patients","status":"RECRUITING","sponsor":"IRCCS National Neurological Institute \"C. Mondino\" Foundation","startDate":"2023-05-10","conditions":"Migraine Disorders, Chronic Migraine, Episodic Migraine","enrollment":100},{"nctId":"NCT06562413","phase":"","title":"Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments","status":"RECRUITING","sponsor":"IRCCS National Neurological Institute \"C. Mondino\" Foundation","startDate":"2023-05-10","conditions":"Migraine Disorders, Chronic Migraine, Episodic Migraine","enrollment":100},{"nctId":"NCT06562400","phase":"","title":"Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to Treatments","status":"RECRUITING","sponsor":"IRCCS National Neurological Institute \"C. Mondino\" Foundation","startDate":"2023-05-10","conditions":"Migraine Disorders, Chronic Migraine, Episodic Migraine","enrollment":45},{"nctId":"NCT06510751","phase":"","title":"Evaluation of the Levels of Calcitonin Gene-related Peptide and Substance P","status":"RECRUITING","sponsor":"Melike Cengiz","startDate":"2024-03-01","conditions":"Meningitis, Diagnosis, Prognosis","enrollment":51},{"nctId":"NCT01856920","phase":"PHASE2","title":"QUILT-3.006 for Recurrent Medullary Thyroid Cancer","status":"COMPLETED","sponsor":"NantCell, Inc.","startDate":"2013-03-26","conditions":"Medullary Thyroid Cancer (MTC)","enrollment":35},{"nctId":"NCT03812991","phase":"PHASE4","title":"The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2019-07-01","conditions":"Pelvic Ring Fractures","enrollment":21},{"nctId":"NCT05895500","phase":"","title":"Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia","status":"COMPLETED","sponsor":"Nvision Laser Eye Centers","startDate":"2023-05-10","conditions":"Dry Eye, Asthenopia","enrollment":103},{"nctId":"NCT05284019","phase":"PHASE4","title":"Real World Effectiveness of Eptinezumab in Participants With Migraine","status":"TERMINATED","sponsor":"H. Lundbeck A/S","startDate":"2022-03-04","conditions":"Migraine","enrollment":32},{"nctId":"NCT05812742","phase":"NA","title":"Chasing Biomarkers in Post-concussion Syndrome","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2015-03","conditions":"Post Concussive Symptoms","enrollment":86},{"nctId":"NCT05162027","phase":"PHASE2","title":"Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE)","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2022-05-26","conditions":"Temporomandibular Disorders","enrollment":5},{"nctId":"NCT05142228","phase":"PHASE2","title":"Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2022-05-31","conditions":"Trigeminal Neuropathy","enrollment":5},{"nctId":"NCT05632133","phase":"PHASE3","title":"The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2022-06-01","conditions":"Effect of Drug, Migraine Disorders","enrollment":200},{"nctId":"NCT06267664","phase":"","title":"Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP)","status":"UNKNOWN","sponsor":"Hospital Clínico Universitario de Valladolid","startDate":"2023-12-04","conditions":"Migraine, Migraine Disorders, Migraine With Aura","enrollment":1500},{"nctId":"NCT05785988","phase":"","title":"Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)","status":"UNKNOWN","sponsor":"Hospital Clínico Universitario de Valladolid","startDate":"2019-11-01","conditions":"Migraine, Head Pain","enrollment":600},{"nctId":"NCT06256198","phase":"","title":"Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2024-02","conditions":"Sepsis","enrollment":80},{"nctId":"NCT04218539","phase":"PHASE1","title":"Repeat Dosing of Psilocybin in Migraine Headache","status":"COMPLETED","sponsor":"Yale University","startDate":"2021-08-10","conditions":"Migraine Headache","enrollment":18},{"nctId":"NCT05804500","phase":"NA","title":"RecoveryPlus Telerehab Platform Pilot Study","status":"COMPLETED","sponsor":"NODEHealth Foundation","startDate":"2023-03-27","conditions":"Heart Diseases, Angina, Stable, Angina Pectoris","enrollment":75},{"nctId":"NCT06155123","phase":"","title":"HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs","status":"UNKNOWN","sponsor":"IRCCS National Neurological Institute \"C. Mondino\" Foundation","startDate":"2020-01-14","conditions":"Migraine Disorders, Chronic Migraine, Episodic Migraine","enrollment":60},{"nctId":"NCT04796766","phase":"NA","title":"Human Electrophysiological Model to Quantify the CGRP-related Axon Reflex of Trigeminal Afferents","status":"UNKNOWN","sponsor":"University Hospital Tuebingen","startDate":"2021-02-01","conditions":"Migraine","enrollment":72},{"nctId":"NCT05635604","phase":"NA","title":"Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients.","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2023-03-01","conditions":"Migraine","enrollment":38},{"nctId":"NCT03921788","phase":"","title":"Neuropeptides and Venous Pelvic Pain","status":"COMPLETED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2019-04-01","conditions":"Pelvic Pain, Varicose Veins Pelvic, Pelvic Congestion Syndrome","enrollment":120},{"nctId":"NCT06067594","phase":"","title":"Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma.","status":"COMPLETED","sponsor":"Austral University, Argentina","startDate":"2018-03-01","conditions":"Medullary Thyroid Carcinoma, Nodular Goiter","enrollment":155},{"nctId":"NCT05492695","phase":"PHASE4","title":"Tandem OnabotulinumtoxinA Galcanezumab Emerging Therapeutic Headache Elimination Research Study","status":"TERMINATED","sponsor":"Diamond Headache Clinic","startDate":"2022-10-01","conditions":"Migraine","enrollment":2},{"nctId":"NCT04064814","phase":"PHASE4","title":"Evaluation of Efficacy and Safety of add-on Alpha-lipoic Acid on Migraine Prophylaxis in Adolescent Population","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2019-09-14","conditions":"Adolescent Migraine","enrollment":60},{"nctId":"NCT05366621","phase":"","title":"Post-fracture Medication and Mortality","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-11-01","conditions":"Osteoporosis, Osteoporosis Fracture, Drug Therapy","enrollment":216155},{"nctId":"NCT05796115","phase":"NA","title":"PROcalcitonin and Presepsin-guided Decision for Antibiotic Prophylaxis of EOS","status":"UNKNOWN","sponsor":"University of Florence","startDate":"2023-04-01","conditions":"Early-Onset Neonatal Sepsis","enrollment":266},{"nctId":"NCT05768828","phase":"","title":"Stimulation-evoked Calcitonin Gene-Related Peptide (CGRP) as Biomarker of Migraine","status":"UNKNOWN","sponsor":"University Medicine Greifswald","startDate":"2023-02-20","conditions":"Migraine","enrollment":20},{"nctId":"NCT05692297","phase":"NA","title":"Denosumab Treatment in CKD Patients at High Risk of Fracture","status":"UNKNOWN","sponsor":"Capital Medical University","startDate":"2023-01-01","conditions":"Chronic Kidney Diseases, Fracture, Bone Density, Low","enrollment":102},{"nctId":"NCT04592952","phase":"PHASE4","title":"Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab","status":"UNKNOWN","sponsor":"Danish Headache Center","startDate":"2020-10-08","conditions":"Migraine","enrollment":400},{"nctId":"NCT03737916","phase":"NA","title":"The Effect of Perineural Dextrose Injection in Patients With Ulnar Neuropathy at the Elbow","status":"COMPLETED","sponsor":"Ankara Education and Research Hospital","startDate":"2018-11-18","conditions":"Ulnar Neuropathies","enrollment":60},{"nctId":"NCT02466334","phase":"NA","title":"CGRP's Cluster Headache Inducing Abilities in Cluster Headache Patients","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2015-06","conditions":"Cluster Headache","enrollment":37},{"nctId":"NCT01924052","phase":"NA","title":"CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2013-06","conditions":"Migraine Without Aura","enrollment":40},{"nctId":"NCT05442008","phase":"","title":"Predictive Role of MIDAS Reduction at 3 Months for Erenumab Treatment","status":"COMPLETED","sponsor":"IRCCS National Neurological Institute \"C. Mondino\" Foundation","startDate":"2018-12-01","conditions":"Migraine","enrollment":53},{"nctId":"NCT04260087","phase":"","title":"New Daily Persistent Headache Biomarkers Study","status":"TERMINATED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-05-01","conditions":"New Daily Persistent Headache, New Daily Persistent Headache (NDPH)","enrollment":8},{"nctId":"NCT03342001","phase":"PHASE4","title":"Hypothyroidism Treated With Calcitonin","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2018-06-18","conditions":"Hypothyroidism","enrollment":11},{"nctId":"NCT03647657","phase":"EARLY_PHASE1","title":"177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2018-12-13","conditions":"Thyroid Cancer, Medullary","enrollment":8},{"nctId":"NCT02621931","phase":"PHASE3","title":"Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2016-03-22","conditions":"Migraine","enrollment":1130},{"nctId":"NCT02629861","phase":"PHASE3","title":"Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2016-03-23","conditions":"Migraine","enrollment":875},{"nctId":"NCT03828539","phase":"PHASE4","title":"Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2019-02-22","conditions":"Migraine","enrollment":777},{"nctId":"NCT03333109","phase":"PHASE3","title":"Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-02-08","conditions":"Episodic Migraine","enrollment":900},{"nctId":"NCT04993456","phase":"","title":"Calcitonin Level and New-onset of Post-Operative Atrial Fibrillation","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2021-06-15","conditions":"Calcitonin Secretion Disorder, Post-operative Atrial Fibrillation","enrollment":200},{"nctId":"NCT01250574","phase":"","title":"Neutrophil CD64 and Procalcitonin as Novel Biomarkers for Postoperative Infections","status":"COMPLETED","sponsor":"University Hospital, Akershus","startDate":"2010-11","conditions":"Bacterial Infection, Postoperative Infection, Abdominal Infection","enrollment":173},{"nctId":"NCT04334850","phase":"NA","title":"Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-20","conditions":"Covid19, Pneumonia","enrollment":194},{"nctId":"NCT03630120","phase":"PHASE2","title":"Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer","status":"TERMINATED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-08-06","conditions":"Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer","enrollment":6},{"nctId":"NCT04019496","phase":"","title":"Neurophysiology of Prophylactic Treatment in Migraine","status":"COMPLETED","sponsor":"University Medicine Greifswald","startDate":"2019-01-29","conditions":"Migraine","enrollment":44},{"nctId":"NCT04881786","phase":"NA","title":"Calcitonin Gene-related Peptide Expression in Human Periodontal Ligament","status":"COMPLETED","sponsor":"Institucion Universitaria Colegios de Colombia","startDate":"2019-06-04","conditions":"CGRP Expression in Human Periodontal Ligament","enrollment":90},{"nctId":"NCT04452929","phase":"NA","title":"The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients","status":"UNKNOWN","sponsor":"Danish Headache Center","startDate":"2020-07-22","conditions":"Migraine, Migraine Without Aura, Migraine With Aura","enrollment":72},{"nctId":"NCT03401619","phase":"","title":"Beijing Osteoporosis With Neurological Disorders in Epigenetic Changes Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2017-09-21","conditions":"Osteoporosis，Neurological Disorders","enrollment":2000},{"nctId":"NCT03791515","phase":"NA","title":"Clinical Characteristics and Pathophysiology of Post-Traumatic Headache","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2018-07-26","conditions":"Post-Traumatic Headache, Concussion, Mild","enrollment":200},{"nctId":"NCT03053999","phase":"","title":"Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)","status":"UNKNOWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-10-09","conditions":"Multiple Endocrine Neoplasia, Pancreatic Neuroendocrine Tumors, Hyperparathyroidism","enrollment":53},{"nctId":"NCT03542357","phase":"NA","title":"The Effect of Sumatriptan and Placebo on CGRP Induced Headache","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2018-02-15","conditions":"Migraine","enrollment":30},{"nctId":"NCT00486434","phase":"PHASE3","title":"Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Nordic Bioscience A/S","startDate":"2007-05","conditions":"Osteoarthritis","enrollment":1176},{"nctId":"NCT00704847","phase":"PHASE3","title":"Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)","status":"TERMINATED","sponsor":"Nordic Bioscience A/S","startDate":"2008-06","conditions":"Osteoarthritis","enrollment":1030},{"nctId":"NCT03923803","phase":"","title":"Diagnostic Values of C-reactive Protein and Procalcitonin in Predicting Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-07","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":90},{"nctId":"NCT01315847","phase":"PHASE1","title":"Positron Emission Tomography (PET) Study of Brain Calcitonin Gene-Related Peptide (CGRP) Receptor Occupancy After Telcagepant Administration (MK-0974-067)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-01-14","conditions":"Migraine","enrollment":10},{"nctId":"NCT03143465","phase":"NA","title":"Pharmacologically Triggered Migraine Without Aura and Neuroimaging","status":"UNKNOWN","sponsor":"Danish Headache Center","startDate":"2016-08","conditions":"Migraine With Aura","enrollment":36},{"nctId":"NCT02898948","phase":"","title":"Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2016-02-11","conditions":"Systemic Inflammatory Response Syndrome, Fever","enrollment":116},{"nctId":"NCT02130986","phase":"NA","title":"Procalcitonin Antibiotic Consensus Trial (ProACT)","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2014-11-03","conditions":"Lower Respiratory Tract Infection (LRTI)","enrollment":1664},{"nctId":"NCT01294709","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-02-12","conditions":"Angina Pectoris, Coronary Heart Disease, Calcitonin Gene-related Peptide Receptor","enrollment":64},{"nctId":"NCT03636945","phase":"NA","title":"Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2018-10","conditions":"Medullary Thyroid Carcinoma","enrollment":62},{"nctId":"NCT02392689","phase":"NA","title":"Improve Management of Heart Failure With Procalcitonin","status":"TERMINATED","sponsor":"Brahms AG","startDate":"2015-03","conditions":"Heart Failure, Infection","enrollment":759},{"nctId":"NCT03557541","phase":"NA","title":"Sardine-enriched Diet for Prevention Type 2 Diabetes","status":"COMPLETED","sponsor":"Institut d'Investigacions Biomèdiques August Pi i Sunyer","startDate":"2014-05","conditions":"Diabetes Mellitus, Type 2, PreDiabetes, Diet Habit","enrollment":182},{"nctId":"NCT02085733","phase":"","title":"Pro-calcitonin for Early Detection of Septic Arthritis","status":"COMPLETED","sponsor":"Children's Hospitals and Clinics of Minnesota","startDate":"2014-02","conditions":"Arthritis, Infectious","enrollment":150},{"nctId":"NCT03481400","phase":"NA","title":"CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment","status":"UNKNOWN","sponsor":"Danish Headache Center","startDate":"2016-07","conditions":"Migraine","enrollment":40},{"nctId":"NCT00478335","phase":"NA","title":"Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2007-05","conditions":"Nephrogenic Diabetes Insipidus","enrollment":4},{"nctId":"NCT03223233","phase":"","title":"Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels","status":"COMPLETED","sponsor":"Kanuni Sultan Suleyman Training and Research Hospital","startDate":"2017-05-02","conditions":"Wound Infection, Cesarean Wound Disruption","enrollment":90},{"nctId":"NCT01652573","phase":"NA","title":"Calcitonin for Treating X-linked Hypophosphatemia","status":"COMPLETED","sponsor":"Yale University","startDate":"2011-03","conditions":"Hypophosphatemic Rickets, X Linked Dominant","enrollment":21},{"nctId":"NCT03058718","phase":"NA","title":"Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis","status":"COMPLETED","sponsor":"Qilu Hospital of Shandong University","startDate":"2014-01-01","conditions":"Procalcitonin, Bronchiectasis, Antibiotic Therapy","enrollment":210},{"nctId":"NCT02115360","phase":"NA","title":"Epidural Calcitonin in Lower Limb Amputation","status":"COMPLETED","sponsor":"Tanta University","startDate":"2014-04","conditions":"Amputation Stumps","enrollment":60},{"nctId":"NCT02881892","phase":"","title":"Iplasma IL6, Procalcitonin and VEGF and Dialysate Level in CAPD Patients","status":"COMPLETED","sponsor":"Bangkok Metropolitan Administration Medical College and Vajira Hospital","startDate":"2012-03","conditions":"Chronic Kidney Disease","enrollment":26},{"nctId":"NCT00688077","phase":"NA","title":"FGF-23 Suppressibility by Calcitonin","status":"COMPLETED","sponsor":"Rijnstate Hospital","startDate":"2008-05","conditions":"Hypophosphatemia","enrollment":49},{"nctId":"NCT00754884","phase":"PHASE4","title":"Calcitonin in the Treatment of Fibromyalgia","status":"WITHDRAWN","sponsor":"Unidad de Investigacion en Enfermedades Cronico-Degenerativas","startDate":"2008-10","conditions":"Fibromyalgia","enrollment":""},{"nctId":"NCT00987818","phase":"NA","title":"Procalcitonin Guided Versus Conventional Antibiotic Therapy in Patients With Sepsis in the ICU","status":"WITHDRAWN","sponsor":"Rijnstate Hospital","startDate":"","conditions":"Sepsis, Intensive Care","enrollment":""},{"nctId":"NCT02519998","phase":"","title":"Tissue Repository and Master Database for Concussion Biomarker and Risk Calculator Development","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2015-03","conditions":"Brain Concussion","enrollment":1000},{"nctId":"NCT02358304","phase":"PHASE2","title":"Efficacy of Nasal Spray Calcitonin on Recurrence of Aggressive Central Giant Cell Granuloma","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2007-09","conditions":"Central Giant Cell Granuloma","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Miacalcic nasal spray (Novartis Pharmaceutical)"],"phase":"marketed","status":"active","brandName":"Salmon Calcitonin","genericName":"Salmon Calcitonin","companyName":"Eli Lilly and Company","companyId":"eli-lilly","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Salmon calcitonin is a peptide hormone that binds to calcitonin receptors on osteoclasts to inhibit bone resorption and lower serum calcium levels. Used for Paget's disease of bone, Hypercalcemia of malignancy, Osteoporosis in postmenopausal women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}